Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Kiyomi Mashima, Takashi Ikeda, Yumiko Toda, Shoko Ito, Kento Umino, Daisuke Minakata, Hirofumi Nakano, Kaoru Morita, Ryoko Yamasaki, Yasufumi Kawasaki, Miyuki Sugimoto, Masahiro Ashizawa, Chihiro Yamamoto, Shinichiro Fujiwara, Kaoru Hatano, Kazuya Sato, Iekuni Oh, Ken Ohmine, Kazuo Muroi & Yoshinobu Kanda. (2019) Associations between the peripheral blood Wilms tumor gene 1 level and both bone marrow blast cells and the prognosis in patients with myelodysplastic syndrome. Leukemia & Lymphoma 60:3, pages 703-710.
Read now
Read now
Paula Marlton. (2014) The many facets of WT1 in acute myeloid leukemia: clarity remains elusive. Leukemia & Lymphoma 55:2, pages 235-237.
Read now
Read now
Sheng Luo, Kang Yu, Qing-xian Yan, Zhi-jian Shen, Jian-bo Wu, Hai-min Chen & Shen-meng Gao. (2014) Analysis of WT1 mutations, expression levels and single nucleotide polymorphism rs16754 in de novo non-M3 acute myeloid leukemia. Leukemia & Lymphoma 55:2, pages 349-357.
Read now
Read now
Yasunori Ueda, Chisato Mizutani, Yasuhito Nannya, Mineo Kurokawa, Sumiko Kobayashi, Jin Takeuchi, Hideto Tamura, Kiyoyuki Ogata, Kazuo Dan, Hirohiko Shibayama, Yuzuru Kanakura, Keiko Niimi, Ko Sasaki, Masato Watanabe, Nobuhiko Emi, Masanao Teramura, Toshiko Motoji, Michiko Kida, Kensuke Usuki, Satoru Takada, Toru Sakura, Yoshikazu Ito, Kazuma Ohyashiki, Hiroyasu Ogawa, Takahiro Suzuki, Keiya Ozawa, Kiyotoshi Imai, Masaharu Kasai, Tomoko Hata, Yasushi Miyazaki, Yasuyoshi Morita, Akihisa Kanamaru, Akira Matsuda, Kaoru Tohyama, Daisuke Koga, Hiroya Tamaki, Kinuko Mitani, Tomoki Naoe, Haruo Sugiyama & Fumimaro Takaku. (2013) Clinical evaluation of WT1 mRNA expression levels in peripheral blood and bone marrow in patients with myelodysplastic syndromes. Leukemia & Lymphoma 54:7, pages 1450-1458.
Read now
Read now
Ghada I. Mossallam, Thoraya M. Abdel Hamid & Hossam K. Mahmoud. (2013) Prognostic significance of WT1 expression at diagnosis and end of induction in Egyptian adult acute myeloid leukemia patients. Hematology 18:2, pages 69-73.
Read now
Read now
Gerald B Wertheim & Adam Bagg. (2011) Minimal residual disease testing to predict relapse following transplant for AML and high-grade myelodysplastic syndromes. Expert Review of Molecular Diagnostics 11:4, pages 361-366.
Read now
Read now
Articles from other publishers (25)
Adnan Mansoor, Ariz Akhter, Meer‐Taher Shabani‐Rad, Jean Deschenes, Asli Yilmaz, Kiril Trpkov & Douglas Stewart. (2023) Primary testicular lymphoma demonstrates overexpression of the Wilms tumor 1 gene and different mRNA and miRNA expression profiles compared to nodal diffuse large B‐cell lymphoma. Hematological Oncology 41:5, pages 828-837.
Crossref
Crossref
Ken Ishiyama, Tran Cao Dung, Tatsuya Imi, Kohei Hosokawa, Yasuhito Nannya, Hirohito Yamazaki, Seishi Ogawa & Shinji Nakao. (2022) Clinical significance of the increased expression of the WT1 gene in peripheral blood of patients with acquired aplastic anemia. eJHaem 3:4, pages 1116-1125.
Crossref
Crossref
Atsushi Marumo, Satoshi Wakita, Kaoru Morita, Iekuni Oh, Shinichi Kako, Takashi Toya, Yuho Najima, Noriko Doki, Junya Kanda, Junya Kuroda, Shinichiro Mori, Atsushi Satake, Kensuke Usuki, Nobuhiko Uoshima, Yutaka Kobayashi, Eri Kawata, Yuhei Nagao, Katsuhiro Shono, Motoharu Shibusawa, Jiro Tadokoro, Masao Hagihara, Hitoji Uchiyama, Yasushi Kubota, Shinya Kimura, Sayuri Motomura, Akiko Hashimoto, Hideharu Muto, Eriko Sato, Masao Ogata, Kenjiro Mitsuhashi, Jun Ando, Kenta Date, Yusuke Fujiwara, Kazuki Terada, Shunsuke Yui, Kunihito Arai, Tomoaki Kitano, Miho Miyata, Kazuteru Ohashi, Yoshinobu Kanda & Hiroki Yamaguchi. (2022) NPM1-mutation-based measurable residual disease assessment after completion of two courses of post-remission therapy is a valuable clinical predictor of the prognosis of acute myeloid leukemia. International Journal of Hematology 116:2, pages 199-214.
Crossref
Crossref
Shinpei Harada, Masahiro Onozawa, Daisuke Hidaka, Shota Yokoyama, Hajime Senjo, Shogo Takahashi, Reiki Ogasawara, Minoru Kanaya, Akio Mori, Shuichi Ota, Takeshi Kondo & Takanori Teshima. (2022) Dynamic change in peripheral blood WT1 mRNA levels within three cycles of azacitidine predict treatment response in patients with high-risk myelodysplastic syndromes. Annals of Hematology 101:6, pages 1239-1250.
Crossref
Crossref
Naoko Hosono, Miyuki Ookura, Hiroaki Araie, Mihoko Morita, Kazuhiro Itoh, Yasufumi Matsuda & Takahiro Yamauchi. (2020) Clinical outcomes of gemtuzumab ozogamicin for relapsed acute myeloid leukemia: single-institution experience. International Journal of Hematology 113:3, pages 362-369.
Crossref
Crossref
Cyril Šálek, Jan Vydra, Ela Cerovská, Šárka Šestáková, Šárka Ransdorfová, Veronika Válková, Petr Cetkovský & Hana Remešová. (2020) WT1 Expression in Peripheral Blood at Diagnosis and During the Course of Early Consolidation Treatment Correlates With Survival in Patients With Intermediate and Poor-Risk Acute Myeloid Leukemia. Clinical Lymphoma Myeloma and Leukemia 20:12, pages e998-e1009.
Crossref
Crossref
Amy Y. Wang, Howard Weiner, Margaret Green, Hua Chang, Noreen Fulton, Richard A. Larson, Olatoyosi Odenike, Andrew S. Artz, Michael R. Bishop, Lucy A. Godley, Michael J. Thirman, Satyajit Kosuri, Jane E. Churpek, Emily Curran, Kristen Pettit, Wendy Stock & Hongtao Liu. (2018) A phase I study of selinexor in combination with high-dose cytarabine and mitoxantrone for remission induction in patients with acute myeloid leukemia. Journal of Hematology & Oncology 11:1.
Crossref
Crossref
Kiyomi Mashima, Iekuni Oh, Takashi Ikeda, Yumiko Toda, Shoko Ito, Kento Umino, Daisuke Minakata, Hirofumi Nakano, Kaoru Morita, Ryoko Yamasaki, Yasufumi Kawasaki, Miyuki Sugimoto, Chihiro Yamamoto, Masahiro Ashizawa, Shin-Ichiro Fujiwara, Kaoru Hatano, Kazuya Sato, Ken Omine, Kazuo Muroi & Yoshinobu Kanda. (2018) Role of Sequential Monitoring of WT1 Gene Expression in Patients With Acute Myeloid Leukemia for the Early Detection of Leukemia Relapse. Clinical Lymphoma Myeloma and Leukemia 18:12, pages e521-e527.
Crossref
Crossref
Daisuke Hidaka, Masahiro Onozawa, Junichi Hashiguchi, Naohiro Miyashita, Kohei Kasahara, Shinichi Fujisawa, Eiko Hayase, Kohei Okada, Souichi Shiratori, Hideki Goto, Junichi Sugita, Masao Nakagawa, Daigo Hashimoto, Kaoru Kahata, Tomoyuki Endo, Satoshi Yamamoto, Yutaka Tsutsumi, Yoshihito Haseyama, Takahiro Nagashima, Akio Mori, Shuichi Ota, Hajime Sakai, Toshimichi Ishihara, Kiyotoshi Imai, Takuto Miyagishima, Yasutaka Kakinoki, Mitsutoshi Kurosawa, Hajime Kobayashi, Hiroshi Iwasaki, Chikara Shimizu, Takeshi Kondo & Takanori Teshima. (2018) Wilms Tumor 1 Expression at Diagnosis Correlates With Genetic Abnormalities and Polymorphism But Is Not Independently Prognostic in Acute Myelogenous Leukemia: A Hokkaido Leukemia Net Study. Clinical Lymphoma Myeloma and Leukemia 18:11, pages e469-e479.
Crossref
Crossref
Yun Zhu, Cindy Wang, Scott A. Becker, Katie Hurst, Lourdes M. Nogueira, Victoria J. Findlay & E. Ramsay Camp. (2018) miR-145 Antagonizes SNAI1-Mediated Stemness and Radiation Resistance in Colorectal Cancer. Molecular Therapy 26:3, pages 744-754.
Crossref
Crossref
Joji Nagasaki, Yasutaka Aoyama, Masayuki Hino, Kentaro Ido, Hiroyoshi Ichihara, Masahiro Manabe, Tadanobu Ohta & Atsuko Mugitani. (2017) <b><i>Wilms Tumor 1 </i></b><b>(</b><b><i>WT1</i></b><b>)</b> mRNA Expression Level at Diagnosis Is a Significant Prognostic Marker in Elderly Patients with Myelodysplastic Syndrome. Acta Haematologica 137:1, pages 32-39.
Crossref
Crossref
Sumiko Kobayashi, Yasunori Ueda, Yasuhito Nannya, Hirohiko Shibayama, Hideto Tamura, Kiyoyuki Ogata, Yoshiki Akatsuka, Kensuke Usuki, Yoshikazu Ito, Masaya Okada, Takahiro Suzuki, Tomoko Hata, Akira Matsuda, Kaoru Tohyama, Keiji Kakumoto, Daisuke Koga, Kinuko Mitani, Tomoki Naoe, Haruo Sugiyama & Fumimaro Takaku. (2016) Prognostic significance of Wilms tumor 1 mRNA expression levels in peripheral blood and bone marrow in patients with myelodysplastic syndromes. Cancer Biomarkers 17:1, pages 21-32.
Crossref
Crossref
Nikolai Nikolaevich Mamaev, Ya.V. Gudozhnikova & A.V. Gorbunova. (2016) WT1 Gene Overexpression in Oncohematological Disorders: Theoretical and Clinical Aspects (Literature Review). Clinical oncohematology 9:3, pages 257-264.
Crossref
Crossref
Kunio Kitamura, Takahiro Nishiyama, Ken Ishiyama, Shuichi Miyawaki, Kanji Miyazaki, Kenshi Suzuki, Hiroaki Masaie, Masaya Okada, Hiroyasu Ogawa, Kiyotoshi Imai, Hitoshi Kiyoi, Tomoki Naoe, Yasuhisa Yokoyama, Shigeru Chiba, Tomoko Hata, Yasushi Miyazaki, Yoshihiro Hatta, Jin Takeuchi, Yasuhito Nannya, Mineo Kurokawa, Yasunori Ueda, Daisuke Koga, Haruo Sugiyama & Fumimaro Takaku. (2015) Clinical usefulness of WT1 mRNA expression in bone marrow detected by a new WT1 mRNA assay kit for monitoring acute myeloid leukemia: a comparison with expression of WT1 mRNA in peripheral blood. International Journal of Hematology 103:1, pages 53-62.
Crossref
Crossref
Yasuhiko Shibasaki, Yoshinobu Seki, Tomoyuki Tanaka, Syukuko Miyakoshi, Kyoko Fuse, Takashi Kozakai, Hironori Kobayashi, Takashi Ushiki, Takashi Abe, Toshio Yano, Masato Moriyama, Takashi Kuroha, Noriatsu Isahai, Jun Takizawa, Miwako Narita, Satoru Koyama, Tatsuo Furukawa, Hirohito Sone & Masayoshi Masuko. (2015) The association of level of reduction of Wilms’ tumor gene 1 mRNA transcript in bone marrow and outcome in acute myeloid leukemia patients. Leukemia Research 39:6, pages 667-671.
Crossref
Crossref
Yang Yi-ning, Wang Xiao-rui, Zhao Chu-xian, Wang Chun & Qin You-wen. (2015) Prognostic significance of diagnosed WT1 level in acute myeloid leukemia: a meta-analysis. Annals of Hematology 94:6, pages 929-938.
Crossref
Crossref
Maki Baba, Tomoko Hata, Hideki Tsushima, Sayaka Mori, Daisuke Sasaki, Kazuto Turuta, Hiroo Hasegawa, Koji Ando, Yasushi Sawayama, Daisuke Imanishi, Jun Taguchi, Katsunori Yanagihara, Masao Tomonaga, Shimeru Kamihira & Yasushi Miyazaki. (2015) The Level of Bone Marrow WT1 Message is a Useful Marker to Differentiate Myelodysplastic Syndromes with Low Blast Percentage from Cytopenia due to Other Reasons. Internal Medicine 54:5, pages 445-451.
Crossref
Crossref
A Israyelyan, L Goldstein, W Tsai, L Aquino, S J Forman, R Nakamura & D J Diamond. (2014) Real-time assessment of relapse risk based on the WT1 marker in acute leukemia and myelodysplastic syndrome patients after hematopoietic cell transplantation. Bone Marrow Transplantation 50:1, pages 26-33.
Crossref
Crossref
Xiaodong Lyu, Yaping Xin, Ruihua Mi, Jing Ding, Xianwei Wang, Jieying Hu, Ruihua Fan, Xudong Wei, Yongping Song & Richard Y. Zhao. (2014) Overexpression of Wilms Tumor 1 Gene as a Negative Prognostic Indicator in Acute Myeloid Leukemia. PLoS ONE 9:3, pages e92470.
Crossref
Crossref
Hiroko Tsunemine, Hiroshi Akasaka, Emiko Ishikawa Sakane, Kiminari Ito, Taiichi Kodaka & Takayuki Takahashi. (2013) Successful repeated treatment of acute myeloid leukemia in early relapse with gemtuzumab ozogamicin alone. International Journal of Hematology 99:2, pages 193-197.
Crossref
Crossref
Debmalya Barh, Angelo Carpi, Mukesh Verma & Mehmet GunduzOta Fuchs. 2014. Cancer Biomarkers. Cancer Biomarkers
813
848
.
Carlos Santamaría, Fernando Ramos, Noemi Puig, Eva Barragán, Raquel de Paz, Carme Pedro, Andrés Insunza, Mar Tormo, Consuelo del Cañizo, María Diez-Campelo, Blanca Xicoy, Eduardo Salido, Javier Sánchez del Real, Montserrat Hernández, Carmen Chillón, Guillermo F. Sanz, Ramón García-Sanz, Jesús F. San Miguel & Marcos González. (2012) Simultaneous analysis of the expression of 14 genes with individual prognostic value in myelodysplastic syndrome patients at diagnosis: WT1 detection in peripheral blood adversely affects survival. Annals of Hematology 91:12, pages 1887-1895.
Crossref
Crossref
Akira Shimada, Tomohiko Taki, Daisuke Koga, Ken Tabuchi, Akio Tawa, Ryoji Hanada, Masahiro Tsuchida, Keizo Horibe, Ichiro Tsukimoto, Souichi Adachi, Seiji Kojima & Yasuhide Hayashi. (2012) High WT1 mRNA expression after induction chemotherapy and FLT3-ITD have prognostic impact in pediatric acute myeloid leukemia: a study of the Japanese Childhood AML Cooperative Study Group. International Journal of Hematology 96:4, pages 469-476.
Crossref
Crossref
James X. Gray, Lyle McMillen, Peter Mollee, Sanjoy Paul, Steven Lane, Robert Bird, Devinder Gill, Russell Saal & Paula Marlton. (2012) WT1 expression as a marker of minimal residual disease predicts outcome in acute myeloid leukemia when measured post-consolidation. Leukemia Research 36:4, pages 453-458.
Crossref
Crossref
David T. Yeung, Wendy T. Parker & Susan Branford. (2011) Molecular methods in diagnosis and monitoring of haematological malignancies. Pathology 43:6, pages 566-579.
Crossref
Crossref